title: Entrapment of dispersed pancreatic islet cells in CultiSpher-S macroporous gelatin microcarriers: Preparation, in vitro characterization, and microencapsulation.
abstract: Immunoprotection of pancreatic islets for successful allo- or xenotransplantation without chronic immunosuppression is an attractive, but still elusive, approach for curing type 1 diabetes. It was recently shown that, even in the absence of fibrotic overgrowth, other factors, mainly insufficient nutrition to the core of the islets, represent a major barrier for long-term survival of intraperitoneal microencapsulated islet grafts. The use of dispersed cells might contribute to solve this problem due to the conceivably easier nutritional support to the cells. In the present study, purified bovine islets, prepared by collagenase digestion and density gradient purification, and dispersed bovine islet cells, obtained by trypsin and DNAsi (viability > 90%), were entrapped into either 2% (w/v) sodium alginate (commonly used for encapsulation purposes) or (dispersed islet cells only) macroporous gelatin microcarriers (CulthiSpher-S, commonly used for the production of biologicals by animal cells). Insulin release studies in response to glucose were performed within 1 week and after 1 month from preparation of the varying systems and showed no capability of dispersed bovine islet cells within sodium alginate microcapsules to sense glucose concentration changes. On the contrary, bovine islet cells entrapped in CulthiSpher-S microcarriers showed maintained capacity of increasing insulin secretion upon enhanced glucose concentration challenge. In this case, insulin release was approximately 60% of that from intact bovine islets within sodium alginate microcapsules. MTT and hematoxylineosin staining of islet cell-containing microcarriers showed the presence of viable and metabolically active cells throughout the study period. This encouraging functional data prompted us to test whether the microcarriers could be immunoisolated for potential use in transplantation. The microcarriers were embedded within 3% sodium alginate, which was then covered with a poly-L-lysine layer and a final outer alginate layer. Maintained insulin secretion function of this system was observed, which raises the possibility of using microencapsulated CulthiSpher-S microcarriers, containing dispersed pancreatic islet cells, in experimental transplantation studies.
authors.affiliation: Department of Endocrinology and Metabolism, Metabolic Unit, University of Pisa, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Del Guerra
authors.forename: C
authors.initials: C
authors.lastname: Bracci
authors.forename: K
authors.initials: K
authors.lastname: Nilsson
authors.forename: A
authors.initials: A
authors.lastname: Belcourt
authors.forename: L
authors.initials: L
authors.lastname: Kessler
authors.forename: R
authors.initials: R
authors.lastname: Lupi
authors.forename: L
authors.initials: L
authors.lastname: Marselli
authors.forename: P
authors.initials: P
authors.lastname: De Vos
authors.forename: P
authors.initials: P
authors.lastname: Marchetti
mesh_terms: D000818:Animals; D002417:Cattle; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy; D004339:Drug Compounding; D005780:Gelatin; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000276:immunology / Q000378:metabolism; D016381:Islets of Langerhans Transplantation / Q000276:immunology*
chemical_list: D007328:Insulin; D005780:Gelatin